![]() In the early 2000s, remote monitoring of implantable cardiac devices such as implantable defibrillators (ICDs) was introduced. In the late 1980s, telephone-call-based remote assistance was specialized for HF to monitor the status of HF. Over the last three decades, the management of patients with HF has changed from in-hospital to remote monitoring due to advances in technology. To prevent hospital admissions, patients must be closely monitored to assess changes in physiological parameters related to congestion that may warrant adjustment of HF therapy. Changes in hemodynamics are usually apparent several days to weeks before the onset of symptoms and signs leading to hospital admission. Symptoms associated with HF hospitalization are often due to increased filling pressures, which result in pulmonary and systemic venous congestion. Patients are usually admitted to a hospital for worsening HF because of signs and symptoms of congestion. Among beneficiaries of Medicare, a significant proportion of discharged patients with HF are readmitted to the hospital. ![]() HF is the primary diagnosis in >1 million hospitalizations annually. Despite therapeutic advances, the rates of hospital admissions for HF remain high. Heart failure (HF) is a major and growing public health problem in both Europe and the United States. This point of view will focus on the remote monitoring of ICDs and CRT-Ds in patients with heart failure and discusses whether remote monitoring can be used as a potential instrument for the early identification of patients at risk of worsening heart failure. Several clinical trials studied the impact of remote monitoring on clinical outcomes in patients with implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization defibrillators (CRT-Ds). Nowadays, remote management of patients with cardiac implantable electronic devices is being increasingly adopted and integrated into clinical practice. Frequent monitoring of high-risk patients is imperative, and with the development of wireless and remote technology, frequent monitoring is now possible via remote monitoring. There is an urgent need to develop strategies to reduce hospitalizations and readmission rates due to heart failure. The management of heart failure remains challenging despite evidence-based medical and pharmacological advances, especially in the ambulatory setting.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |